tiprankstipranks
Trending News
More News >
Captor Therapeutics SA (PL:CTX)
STUTTGART:CTX
Poland Market

Captor Therapeutics SA (CTX) Ratios

Compare
0 Followers

Captor Therapeutics SA Ratios

PL:CTX's free cash flow for Q3 2025 was zł―. For the 2025 fiscal year, PL:CTX's free cash flow was decreased by zł and operating cash flow was zł―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.29 3.90 3.32 7.57 7.98
Quick Ratio
5.29 3.90 3.32 7.57 7.98
Cash Ratio
1.59 1.96 2.83 5.30 7.21
Solvency Ratio
-3.35 -1.45 -2.32 -1.58 -1.32
Operating Cash Flow Ratio
-0.19 -1.58 -1.95 -1.71 -1.74
Short-Term Operating Cash Flow Coverage
-2.11 -11.52 0.00 0.00 0.00
Net Current Asset Value
zł 40.15Mzł 55.06Mzł 60.57Mzł 84.65Mzł 111.22M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.06 0.04 0.06 0.06
Debt-to-Equity Ratio
0.03 0.09 0.05 0.07 0.07
Debt-to-Capital Ratio
0.03 0.08 0.05 0.07 0.06
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.23 1.36 1.41 1.17 1.16
Debt Service Coverage Ratio
-28.56 -10.34 -200.68 -80.22 -62.02
Interest Coverage Ratio
-110.83 -102.43 -226.06 -119.51 -79.27
Debt to Market Cap
<0.01 0.01 0.00 0.00 0.00
Interest Debt Per Share
0.33 1.30 0.88 1.74 2.08
Net Debt to EBITDA
0.39 1.02 1.11 2.27 4.50
Profitability Margins
Gross Profit Margin
39.29%40.59%52.28%77.21%81.41%
EBIT Margin
-361.41%-240.06%-532.22%-388.44%-807.12%
EBITDA Margin
-315.14%-208.09%-490.60%-308.16%-612.39%
Operating Profit Margin
-385.40%-282.84%-553.11%-418.91%-795.48%
Pretax Profit Margin
-355.64%-242.82%-534.25%-391.94%-817.16%
Net Profit Margin
-355.64%-242.82%-534.69%-364.97%-827.20%
Continuous Operations Profit Margin
-355.64%-242.82%-534.69%-391.94%-817.16%
Net Income Per EBT
100.00%100.00%100.08%93.12%101.23%
EBT Per EBIT
92.28%85.85%96.59%93.56%102.72%
Return on Assets (ROA)
-71.70%-43.92%-72.55%-29.58%-22.97%
Return on Equity (ROE)
-77.21%-59.60%-101.97%-34.70%-26.55%
Return on Capital Employed (ROCE)
-93.98%-66.34%-103.48%-38.51%-24.93%
Return on Invested Capital (ROIC)
-90.64%-61.35%-99.97%-34.57%-24.24%
Return on Tangible Assets
-72.10%-44.13%-72.78%-29.78%-23.03%
Earnings Yield
-10.49%-19.50%-15.19%-5.01%-4.44%
Efficiency Ratios
Receivables Turnover
10.07 0.41 2.07 0.95 0.34
Payables Turnover
1.05 3.55 0.97 0.49 0.32
Inventory Turnover
0.00 0.00 0.00 2.09M 0.00
Fixed Asset Turnover
3.44 1.79 1.63 0.86 0.32
Asset Turnover
0.20 0.18 0.14 0.08 0.03
Working Capital Turnover Ratio
0.25 0.26 0.18 0.09 0.07
Cash Conversion Cycle
-311.49 779.48 -200.63 -365.96 -59.03
Days of Sales Outstanding
36.24 882.32 176.13 385.73 1.07K
Days of Inventory Outstanding
0.00 0.00 0.00 <0.01 0.00
Days of Payables Outstanding
347.72 102.84 376.76 751.69 1.13K
Operating Cycle
36.24 882.32 176.13 385.73 1.07K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.32 -6.79 -11.24 -5.51 -6.90
Free Cash Flow Per Share
0.39 -6.88 -11.88 -5.72 -8.14
CapEx Per Share
1.04 0.09 0.65 0.21 1.24
Free Cash Flow to Operating Cash Flow
-1.21 1.01 1.06 1.04 1.18
Dividend Paid and CapEx Coverage Ratio
-0.31 -74.62 -17.37 -25.73 -5.57
Capital Expenditure Coverage Ratio
-0.31 -74.62 -17.37 -25.73 -5.57
Operating Cash Flow Coverage Ratio
-1.22 -5.61 -13.82 -3.30 -3.48
Operating Cash Flow to Sales Ratio
-0.16 -2.00 -3.95 -2.51 -7.14
Free Cash Flow Yield
0.57%-16.27%-11.88%-3.57%-4.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-9.53 -5.13 -6.58 -19.95 -22.51
Price-to-Sales (P/S) Ratio
33.97 12.45 35.19 72.82 186.20
Price-to-Book (P/B) Ratio
8.40 3.06 6.71 6.92 5.98
Price-to-Free Cash Flow (P/FCF) Ratio
176.18 -6.15 -8.41 -27.97 -22.10
Price-to-Operating Cash Flow Ratio
-212.58 -6.23 -8.90 -29.06 -26.07
Price-to-Earnings Growth (PEG) Ratio
-2.03 0.11 -0.07 -53.14 -0.23
Price-to-Fair Value
8.40 3.06 6.71 6.92 5.98
Enterprise Value Multiple
-10.39 -4.96 -6.06 -21.36 -25.91
Enterprise Value
363.29M 163.48M 392.65M 602.82M 632.45M
EV to EBITDA
-10.39 -4.96 -6.06 -21.36 -25.91
EV to Sales
32.73 10.33 29.74 65.82 158.67
EV to Free Cash Flow
169.76 -5.10 -7.11 -25.29 -18.83
EV to Operating Cash Flow
-205.25 -5.17 -7.52 -26.27 -22.21
Tangible Book Value Per Share
8.06 13.75 14.83 22.92 30.00
Shareholders’ Equity Per Share
8.12 13.84 14.90 23.11 30.09
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 >-0.01 0.07 -0.01
Revenue Per Share
2.01 3.40 2.84 2.20 0.97
Net Income Per Share
-7.16 -8.25 -15.19 -8.02 -7.99
Tax Burden
1.00 1.00 1.00 0.93 1.01
Interest Burden
0.98 1.01 1.00 1.01 1.01
Research & Development to Revenue
3.47 2.19 4.91 4.82 5.80
SG&A to Revenue
1.15 0.26 1.22 2.14 4.90
Stock-Based Compensation to Revenue
0.04 0.00 0.35 0.87 2.38
Income Quality
0.04 0.82 0.74 0.64 0.87
Currency in PLN